17 results on '"Liew, KC"'
Search Results
2. Genome dynamics across the evolutionary transition to endosymbiosis.
- Author
-
Siozios S, Nadal-Jimenez P, Azagi T, Sprong H, Frost CL, Parratt SR, Taylor G, Brettell L, Liew KC, Croft L, King KC, Brockhurst MA, Hypša V, Novakova E, Darby AC, and Hurst GDD
- Subjects
- Biological Evolution, Gene Transfer, Horizontal, Evolution, Molecular, Enterobacteriaceae genetics, Enterobacteriaceae physiology, Symbiosis genetics, Genome, Bacterial
- Abstract
Endosymbiosis-where a microbe lives and replicates within a host-is an important contributor to organismal function that has accelerated evolutionary innovations and catalyzed the evolution of complex life. The evolutionary processes associated with transitions to endosymbiosis, however, are poorly understood. Here, we leverage the wide diversity of host-associated lifestyles of the genus Arsenophonus to reveal the complex evolutionary processes that occur during the transition to a vertically transmitted endosymbiotic lifestyle from strains maintained solely by horizontal (infectious) transmission. We compared the genomes of 38 strains spanning diverse lifestyles from horizontally transmitted pathogens to obligate interdependent endosymbionts. Among culturable strains, we observed those with vertical transmission had larger genome sizes than closely related horizontally transmitting counterparts, consistent with evolutionary innovation and the rapid gain of new functions. Increased genome size was a consequence of prophage and plasmid acquisition, including a cargo of type III effectors, alongside the concomitant loss of CRISPR-Cas genome defense systems, enabling mobile genetic element expansion. Persistent endosymbiosis was also associated with loss of type VI secretion, which we hypothesize to be a consequence of reduced microbe-microbe competition. Thereafter, the transition to endosymbiosis with strict vertical inheritance was associated with the expected relaxation of purifying selection, gene pseudogenization, metabolic degradation, and genome reduction. We argue that reduced phage predation in endosymbiotic niches drives the loss of genome defense systems driving rapid genome expansion upon the adoption of endosymbiosis and vertical transmission. This remodeling enables rapid horizontal gene transfer-mediated evolutionary innovation and precedes the reductive evolution traditionally associated with adaptation to endosymbiosis., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. A serological assay using Tropheryma whipplei antigens for the presumptive exclusion of Whipple disease.
- Author
-
Liew KC, Nguyen C, Waidyatillake NT, Nguyen T, Walton A, Harris O, Athan E, Stenos J, and Graves SR
- Subjects
- Humans, Seroepidemiologic Studies, Australia, Immunoglobulin G, Tropheryma, Whipple Disease diagnosis, Whipple Disease microbiology
- Abstract
Whipple disease (WD) is a rare infection in genetically susceptible people caused by the bacterium Tropheryma whipplei. An indirect immunofluorescence serological assay (IFA), detecting patient antibodies to the bacterium, was developed using T. whipplei as antigen. We hypothesised that this assay could be used to rule out WD in patients in whom the diagnosis was being considered, based on high immunoglobulin (Ig) G titres to T. whipplei. In this study, 16 confirmed WD patients and 156 age-matched controls from across Australia were compared serologically. WD patients mostly underproduced IgG antibody to T. whipplei, with titres of ≤1:32 being common. While at an antibody titre of <1:64 the assay sensitivity for WD was only 69% [95% confidence interval (CI) 41-89%], its specificity for excluding WD was 91% (95% CI 85-95%). This specificity increased to 95% (95% CI 90-98%) at an antibody titre of <1:16. Patients with antibody titres of >1:64 were unlikely to have WD. At this titre, the seroprevalence of T. whipplei IgG antibody was 92% (223/242) in Australian blood donors. Unlike other serological assays, which are used to confirm a specific infection, this novel assay is designed to rule out WD infection with a specificity in Australia of 91%. Further validation of this assay, by trialling in other countries, should now be undertaken, as its usefulness is dependent on there being a high background seropositivity to T. whipplei in the general population at the location in which the assay is being used., (Copyright © 2023 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
4. Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection.
- Author
-
Lee WS, Tan HX, Reynaldi A, Esterbauer R, Koutsakos M, Nguyen J, Amarasena T, Kent HE, Aggarwal A, Turville SG, Taiaroa G, Kinsella P, Liew KC, Tran T, Williamson DA, Cromer D, Davenport MP, Kent SJ, Juno JA, Khoury DS, and Wheatley AK
- Subjects
- Humans, SARS-CoV-2, Antibodies, Neutralizing, Breakthrough Infections, COVID-19
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection of vaccinated individuals is increasingly common with the circulation of highly immune evasive and transmissible Omicron variants. Here, we report the dynamics and durability of recalled spike-specific humoral immunity following Omicron BA.1 or BA.2 breakthrough infection, with longitudinal sampling up to 8 months after infection. Both BA.1 and BA.2 infections robustly boosted neutralization activity against the infecting strain while expanding breadth against BA.4, although neutralization activity was substantially reduced for the more recent XBB and BQ.1.1 strains. Cross-reactive memory B cells against both ancestral and Omicron spike were predominantly expanded by infection, with limited recruitment of de novo Omicron-specific B cells or antibodies. Modeling of neutralization titers predicts that protection from symptomatic reinfection against antigenically similar strains will be durable but is undermined by new emerging strains with further neutralization escape.
- Published
- 2023
- Full Text
- View/download PDF
5. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses.
- Author
-
Koutsakos M, Reynaldi A, Lee WS, Nguyen J, Amarasena T, Taiaroa G, Kinsella P, Liew KC, Tran T, Kent HE, Tan HX, Rowntree LC, Nguyen THO, Thomas PG, Kedzierska K, Petersen J, Rossjohn J, Williamson DA, Khoury D, Davenport MP, Kent SJ, Wheatley AK, and Juno JA
- Subjects
- Humans, SARS-CoV-2, CD8-Positive T-Lymphocytes, Breakthrough Infections, RNA, Viral, Antibodies, Neutralizing, Antibodies, Viral, Vaccination, COVID-19
- Abstract
Although the protective role of neutralizing antibodies against COVID-19 is well established, questions remain about the relative importance of cellular immunity. Using 6 pMHC multimers in a cohort with early and frequent sampling, we define the phenotype and kinetics of recalled and primary T cell responses following Delta or Omicron breakthrough infection in previously vaccinated individuals. Recall of spike-specific CD4
+ T cells was rapid, with cellular proliferation and extensive activation evident as early as 1 day post symptom onset. Similarly, spike-specific CD8+ T cells were rapidly activated but showed variable degrees of expansion. The frequency of activated SARS-CoV-2-specific CD8+ T cells at baseline and peak inversely correlated with peak SARS-CoV-2 RNA levels in nasal swabs and accelerated viral clearance. Our study demonstrates that a rapid and extensive recall of memory T cell populations occurs early after breakthrough infection and suggests that CD8+ T cells contribute to the control of viral replication in breakthrough SARS-CoV-2 infections., Competing Interests: Declaration of interests M.K. has acted as a consultant for Sanofi group of companies., (Copyright © 2023 Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
6. Insights into the Evolution of P. aeruginosa Antimicrobial Resistance in a Patient Undergoing Intensive Therapy.
- Author
-
Liew KC, O'Keeffe J, Rajandas H, Lee YP, Harris O, Parimannan S, Croft L, and Athan E
- Abstract
Whole genome sequencing (WGS) provides insights into the evolution of antimicrobial resistance, an urgent global health threat. Using WGS, we observe evolutionary adaptation of a Pseudomonas aeruginosa strain within an immunocompromised patient undergoing antibiotic therapy. Two blood isolates (EA-86 and EA-87) from the patient evolved separate adaptations for antibiotic resistance, while sharing common adaptive mutations for host immune evasion. In EA-86, a silencing mutation in the antibiotic efflux pump repressor, NfxB, increased antibiotic resistance, while in EA-87, a similar mutation was seen in the antibiotic efflux pump repressor mexR. The number of genomic variants between the two isolates give a divergence time estimate of the order of 1000 generations. This time is sufficient for a bacterial lineage to have evolved an SNP in every position in the genome and been fixed if advantageous. This demonstrates the evolutionary adaptive power accessible to bacteria and the timescale for a brute-force functional survey of the SNP fitness landscape.
- Published
- 2023
- Full Text
- View/download PDF
7. Mpox diagnostics: Review of current and emerging technologies.
- Author
-
Lim CK, Roberts J, Moso M, Liew KC, Taouk ML, Williams E, Tran T, Steinig E, Caly L, and Williamson DA
- Subjects
- Animals, Humans, Monkeypox virus, Zoonoses, Disease Outbreaks, Mpox, Monkeypox diagnosis, Mpox, Monkeypox epidemiology, Orthopoxvirus
- Abstract
Mpox is a zoonotic disease caused by monkeypox virus (MPXV) from the Orthopoxvirus genus. Unprecedented transmission events have led to more than 70 000 cases reported worldwide by October 2022. The change in mpox epidemiology has raised concerns of its ability to establish endemicity beyond its traditional geographical locations. In this review, we discuss the current understanding of mpox virology and viral dynamics that are relevant to mpox diagnostics. A synopsis of the traditional and emerging laboratory technologies useful for MPXV detection and in guiding "elimination" strategies is outlined in this review. Importantly, development in MPXV genomics has rapidly advanced our understanding of the role of viral evolution and adaptation in the current outbreak., (© 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
8. First human case of infection with Arsenophonus nasoniae, the male killer insect pathogen.
- Author
-
Liew KC, Graves S, Croft L, Brettell LE, Cook J, Botes J, and Newton P
- Subjects
- Adult, Animals, Humans, Insecta, Male, Enterobacteriaceae, Gammaproteobacteria
- Published
- 2022
- Full Text
- View/download PDF
9. The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.
- Author
-
Koutsakos M, Lee WS, Reynaldi A, Tan HX, Gare G, Kinsella P, Liew KC, Taiaroa G, Williamson DA, Kent HE, Stadler E, Cromer D, Khoury DS, Wheatley AK, Juno JA, Davenport MP, and Kent SJ
- Subjects
- Antibodies, Neutralizing, Antibodies, Viral, Humans, SARS-CoV-2, Vaccination, COVID-19, Viral Vaccines
- Abstract
Vaccination against SARS-CoV-2 protects from infection and improves clinical outcomes in breakthrough infections, likely reflecting residual vaccine-elicited immunity and recall of immunological memory. Here, we define the early kinetics of spike-specific humoral and cellular immunity after vaccination of seropositive individuals and after Delta or Omicron breakthrough infection in vaccinated individuals. Early longitudinal sampling revealed the timing and magnitude of recall, with the phenotypic activation of B cells preceding an increase in neutralizing antibody titers. While vaccination of seropositive individuals resulted in robust recall of humoral and T cell immunity, recall of vaccine-elicited responses was delayed and variable in magnitude during breakthrough infections and depended on the infecting variant of concern. While the delayed kinetics of immune recall provides a potential mechanism for the lack of early control of viral replication, the recall of antibodies coincided with viral clearance and likely underpins the protective effects of vaccination against severe COVID-19., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
10. Neonatal parechovirus infection: Possibility of in-utero transmission.
- Author
-
Hilbig A, Liew KC, Foster C, Fuller DG, Chamings A, and Alexandersen S
- Subjects
- Humans, Infant, Newborn, Communicable Diseases, Parechovirus, Picornaviridae Infections diagnosis
- Published
- 2022
- Full Text
- View/download PDF
11. The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteraemia in adults: a retrospective cohort study.
- Author
-
Chiong F, Wasef MS, Liew KC, Cowan R, Tsai D, Lee YP, Croft L, Harris O, Gwini SM, and Athan E
- Subjects
- Adult, Aged, Bacteremia mortality, Bacteremia surgery, Cohort Studies, Female, Humans, Male, Middle Aged, Odds Ratio, Prospective Studies, Pseudomonas Infections mortality, Pseudomonas Infections surgery, Retrospective Studies, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Bacteremia drug therapy, Pseudomonas Infections drug therapy, Pseudomonas aeruginosa, Referral and Consultation
- Abstract
Background: Pseudomonas aeruginosa bacteraemia (PAB) is associated with high mortality. The benefits of infectious diseases consultation (IDC) has been demonstrated in Staphylococcal aureus bacteraemia and other complex infections. Impact of IDC in PAB is unclear. This study aimed to evaluate the impact of IDC on the management and outcomes in patients with PAB., Methods: This is a retrospective cohort single-centre study from 1 November 2006 to 29 May 2019, in all adult patients admitted with first episode of PAB. Data collected included demographics, clinical management and outcomes for PAB and whether IDC occurred. In addition, 29 Pseudomonas aeruginosa (PA) stored isolates were available for Illumina whole genome sequencing to investigate if pathogen factors contributed to the mortality., Results: A total of 128 cases of PAB were identified, 71% received IDC. Patients who received IDC were less likely to receive inappropriate duration of antibiotic therapy (4.4%; vs 67.6%; p < 0.01), more likely to be de-escalated to oral antibiotic in a timely manner (87.9% vs 40.5%; p < 0.01), undergo removal of infected catheter (27.5% vs 13.5%; p = 0.049) and undergo surgical intervention (20.9% vs 5.4%, p = 0.023) for source control. The overall 30-day all-cause mortality rate was 24.2% and was significantly higher in the no IDC group in both unadjusted (56.8% vs 11.0%, odds ratio [OR] = 10.63, p < 0.001) and adjusted analysis (adjusted OR = 7.84; 95% confidence interval, 2.95-20.86). The genotypic analysis did not reveal any PA genetic features associated with increased mortality between IDC versus no IDC groups., Conclusion: Patients who received IDC for PAB had lower 30-day mortality, better source control and management was more compliant with guidelines. Further prospective studies are necessary to determine if these results can be validated in other settings., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
12. Necrotising enterocolitis caused by Clostridium perfringens: a life-threatening manifestation of a common foodborne infection.
- Author
-
Walker HN, Liew KC, Adams V, Larcombe S, Nagra SS, Guest G, and Athan E
- Subjects
- Adult, Clostridium Infections drug therapy, Clostridium perfringens isolation & purification, Endoscopy, Digestive System, Enterocolitis, Necrotizing microbiology, Enterocolitis, Necrotizing therapy, Female, Food Microbiology, Humans, Ileostomy, Tomography, X-Ray Computed, Vancomycin administration & dosage, Clostridium Infections pathology, Enterocolitis, Necrotizing etiology
- Published
- 2020
- Full Text
- View/download PDF
13. An Emerging Human Parechovirus Type 5 Causing Sepsis-Like Illness in Infants in Australia.
- Author
-
Chamings A, Liew KC, Reid E, Athan E, Raditsis A, Vuillermin P, Yoga Y, Caly L, Druce J, and Alexandersen S
- Subjects
- Australia epidemiology, Capsid Proteins, Genotype, High-Throughput Nucleotide Sequencing, Hospitalization, Humans, Infant, Infant, Newborn, Phylogeny, Picornaviridae Infections classification, Picornaviridae Infections physiopathology, Recombination, Genetic, Retrospective Studies, Whole Genome Sequencing, Parechovirus genetics, Parechovirus isolation & purification, Picornaviridae Infections epidemiology, Picornaviridae Infections virology, Sepsis virology
- Abstract
Human parechovirus (HPeV), particularly type 3 (HPeV3), is an important cause of sepsis-/meningitis-like illness in young infants. Laboratory records identified a total of ten HPeV-positive cases in Southeastern Australia between January and July 2019. The HPeV present in these cases were typed by Sanger sequencing of the partial viral capsid protein 1 (VP1) region and selected cases were further characterised by additional Sanger or Ion Torrent near-full length virus sequencing. In seven of the ten cases, an HPeV type 5 (HPeV5) was identified, and in the remaining three cases, an HPeV type 1 was identified. The HPeV5-positive cases were infants under the age of 3 months admitted to hospital with fever, rash, lethargy and/or sepsis-like clinical signs. Near full-length virus sequencing revealed that the HPeV5 was most likely a recombinant virus, with structural genes most similar to an HPeV5 from Belarus in 2018, and a polymerase gene most similar to an HPeV3 from Australia in 2013/14. While HPeV5 is not typically associated with severe clinical signs, the HPeV5 identified here may have been able to cause more severe disease in young infants through the acquisition of genes from a more virulent HPeV.
- Published
- 2019
- Full Text
- View/download PDF
14. Targeting antimicrobial stewardship in hospitalised patients with community-acquired pneumonia within 24 h of admission.
- Author
-
Liew KC, Bartolo C, O'Reilly M, and Lim L
- Abstract
Background: Over-prescribing in patients with respiratory tract infections is common in Australian hospitals. Senior registrar stewardship input within 24 h of admission in hospitalised patients was assessed to determine if this would improve appropriateness., Methods: Interventional, non-randomised, case-controlled study over six-month period. Patients diagnosed with pneumonia admitted under General Medicine were discussed at morning handover and assessed by a senior registrar within the first 24 h of admission with real-time stewardship feedback provided. Controls did not receive stewardship advice. Appropriateness of antibiotic use was assessed using Therapeutic Guidelines., Results: In total, 48 patients had an intervention with 49 controls. Ceftriaxone-based regimens were the most commonly prescribed (control 63%; pre-intervention 70%; post-intervention 51%). The senior registrar recommended changes in 26 patients (55%) with 71% uptake of recommendations. The most common recommendation was de-escalation from ceftriaxone-regimen in patients with CORB scores of 0 and 1 (79%; n = 16/20). Post-intervention antibiotic prescribing improved from <5% to 50% in patients with CORB scores of 0 and 1 (p-value <0.05)., Conclusion: Our results demonstrate that involvement of a senior registrar embedded in the treating team is effective in providing timely advice to influence common hospital over-prescribing in patients with pneumonia. This enhances other antimicrobial stewardship activities such as electronic approval systems and dedicated post-prescribing rounds by Antimicrobial Stewardship team., (Copyright © 2018 Australasian College for Infection Prevention and Control. Published by Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
15. Pyrexia of unknown origin associated with rosuvastatin.
- Author
-
Liew KC, Anpalahan M, and Wadhwa V
- Subjects
- Humans, Hyperlipidemias drug therapy, Male, Middle Aged, Multiple Sclerosis drug therapy, Trigeminal Neuralgia drug therapy, Anticholesteremic Agents adverse effects, Fever of Unknown Origin etiology, Rosuvastatin Calcium adverse effects
- Published
- 2016
- Full Text
- View/download PDF
16. Lignin biodegradation and ligninolytic enzyme studies during biopulping of Acacia mangium wood chips by tropical white rot fungi.
- Author
-
Liew CY, Husaini A, Hussain H, Muid S, Liew KC, and Roslan HA
- Abstract
White rot fungi are good lignin degraders and have the potential to be used in industry. In the present work, Phellinus sp., Daedalea sp., Trametes versicolor and Pycnoporus coccineus were selected due to their relatively high ligninolytic enzyme activity, and grown on Acacia mangium wood chips under solid state fermentation. Results obtained showed that manganese peroxidase produced is far more compared to lignin peroxidase, suggesting that MnP might be the predominating enzymes causing lignin degradation in Acacia mangium wood chips. Cellulase enzyme assays showed that no significant cellulase activity was detected in the enzyme preparation of T. versicolor and Phellinus sp. This low cellulolytic activity further suggests that these two white rot strains are of more interest in lignin degradation. The results on lignin losses showed 20-30% of lignin breakdown at 60 days of biodegradation. The highest lignin loss was found in Acacia mangium biotreated with T. versicolor after 60 days and recorded 26.9%, corresponding to the percentage of their wood weight loss recorded followed by P. coccineus. In general, lignin degradation was only significant from 20 days onwards. The overall percentage of lignin weight loss was within the range of 1.02-26.90% over the biodegradation periods. Microscopic observations conducted using scanning electron microscope showed that T. versicolor, P. coccineus, Daedalea sp. and Phellinus sp. had caused lignin degradation in Acacia mangium wood chips.
- Published
- 2011
- Full Text
- View/download PDF
17. Structural and functional changes with depth in microbial communities in a tropical Malaysian peat swamp forest.
- Author
-
Jackson CR, Liew KC, and Yule CM
- Subjects
- Archaea classification, Archaea enzymology, Bacteria classification, Bacteria enzymology, Gene Library, Geologic Sediments microbiology, RNA, Archaeal genetics, RNA, Bacterial genetics, RNA, Ribosomal, 16S genetics, Sequence Analysis, DNA, Wetlands, Archaea genetics, Bacteria genetics, Ecosystem, Trees microbiology
- Abstract
Tropical peat swamp forests are important and endangered ecosystems, although little is known of their microbial diversity and ecology. We used molecular and enzymatic techniques to examine patterns in prokaryotic community structure and overall microbial activity at 0-, 10-, 20-, and 50-cm depths in sediments in a peat swamp forest in Malaysia. Denaturing gradient gel electrophoresis profiles of amplified 16S ribosomal ribonucleic acid (rRNA) gene fragments showed that different depths harbored different bacterial assemblages and that Archaea appeared to be limited to the deeper samples. Cloning and sequencing of longer 16S rRNA gene fragments suggested reduced microbial diversity in the deeper samples compared to the surface. Bacterial clone libraries were largely dominated by ribotypes affiliated with the Acidobacteria, which accounted for at least 27-54% of the sequences obtained. All of the sequenced representatives from the archaeal clone libraries were Crenarchaeota. Activities of microbial extracellular enzymes involved in carbon, nitrogen, and phosphorus cycling declined appreciably with depth, the only exception being peroxidase. These results show that tropical peat swamp forests are unusual systems with microbial assemblages dominated by members of the Acidobacteria and Crenarchaeota. Microbial communities show clear changes with depth, and most microbial activity is likely confined to populations in the upper few centimeters, the site of new leaf litter fall, rather than the deeper, older, peat layers.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.